MedPath

Effect of Intraoperative IV Ketamine on Postoperative Morphine Consumption During Intestinal Surgery

Not Applicable
Conditions
Postoperative Analgesia
Interventions
Drug: Ketamine Hydrochloride
Drug: Normal saline
Registration Number
NCT03344393
Lead Sponsor
Assiut University
Brief Summary

.The aim of this study is to identify the analgesic effect of intraoperative ketamine intravenous infusion on patients undergoing intestinal surgery and its effect on salivary cortisol and alpha amylase levels as indicator of its effect.

Detailed Description

I- Group K (ketamine): 30 patients will receive intraoperative intravenous ketamine infusion.

II- Group C (control): 30 patients will receive intraoperative intravenous normal saline infusion.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
    • Patient's status ASA status-I and II.
  • Patients age above 18 years old.
  • Patients scheduled for intestinal surgery.
Read More
Exclusion Criteria
  • Patient refusal.
  • Patients with known allergy to ketamine or morphine.
  • Patients with significant hepatic dysfunction.
  • Patients with severe renal disease.
  • Significant Heart disease.
  • Patients with chronic pain.
  • Regular use analgesics, antidepressants or opioids in last 2 months.
  • Any known convulsive disorder.
  • Morbid obesity (BMI>35).
  • Patients with autoimmune disease
  • Patients on corticosteroid therapy
  • Pregnancy.
  • Breast feeding.
  • Woman under hormonal treatment.
  • Oral disease.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketamine hydrochlorideKetamine Hydrochlorideintravenous ketamine infusion in the intraoperative period
normal salineNormal salineintravenous normal saline infusion in the intraoperative period
Primary Outcome Measures
NameTimeMethod
morphine consumption2 days postoperative

IV PCA

Secondary Outcome Measures
NameTimeMethod
cortisol level2 days postoperative

salivary

alpha amylase level2 days postoperative

salivary

© Copyright 2025. All Rights Reserved by MedPath